KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Prepaid Assets (2016 - 2025)

Jazz Pharmaceuticals (JAZZ) has 16 years of Prepaid Assets data on record, last reported at $152.5 million in Q4 2025.

  • For Q4 2025, Prepaid Assets fell 14.05% year-over-year to $152.5 million; the TTM value through Dec 2025 reached $152.5 million, down 14.05%, while the annual FY2025 figure was $152.5 million, 14.05% down from the prior year.
  • Prepaid Assets reached $152.5 million in Q4 2025 per JAZZ's latest filing, up from $146.9 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $354.2 million in Q3 2024 and bottomed at $91.9 million in Q4 2022.
  • Average Prepaid Assets over 5 years is $192.0 million, with a median of $152.5 million recorded in 2025.
  • Peak YoY movement for Prepaid Assets: skyrocketed 286.07% in 2021, then tumbled 63.58% in 2022.
  • A 5-year view of Prepaid Assets shows it stood at $252.4 million in 2021, then crashed by 63.58% to $91.9 million in 2022, then soared by 249.04% to $320.8 million in 2023, then tumbled by 44.7% to $177.4 million in 2024, then decreased by 14.05% to $152.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $152.5 million in Q4 2025, $146.9 million in Q3 2025, and $297.6 million in Q2 2025.